- Home
- SEV vs INO Comparison
SEV vs INO Comparison
Compare SEV & INO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SEV | INO |
|---|---|---|
| Founded | 2019 | 1979 |
| Country | United States | United States |
| Employees | 46 | N/A |
| Industry | Auto Manufacturing | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 99.2M | 114.0M |
| IPO Year | N/A | 1999 |
Fundamental Metrics
Financial Performance| Metric | SEV | INO |
|---|---|---|
| Price | $2.96 | $1.14 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $6.75 |
| AVG Volume (30 Days) | 238.0K | ★ 3.0M |
| Earning Date | 05-16-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 54.18 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $42,220,086.00 |
| Revenue This Year | N/A | $20,156.19 |
| Revenue Next Year | $17,757.14 | $421.95 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 19.37 |
| 52 Week Low | $1.29 | $1.03 |
| 52 Week High | $11.24 | $2.86 |
Technical Indicators
Market Signals| Indicator | SEV | INO |
|---|---|---|
| Relative Strength Index (RSI) | 50.43 | 36.80 |
| Support Level | $2.37 | $1.03 |
| Resistance Level | $3.26 | $1.23 |
| Average True Range (ATR) | 0.24 | 0.06 |
| MACD | -0.00 | 0.01 |
| Stochastic Oscillator | 35.80 | 58.97 |
Price Performance
Historical ComparisonAbout SEV Aptera Motors Corp.
Aptera Motors Corp engages in the development, production, and distribution of energy efficient solar-powered, battery-electric vehicles. The company has designed the Aptera vehicle to provide up to an estimated 40 miles per day by collecting energy from the sun and storing it in its proprietary battery pack. The company operates as a single reportable segment focused on the development of solar electric vehicles.
About INO Inovio Pharmaceuticals Inc.
Inovio Pharmaceuticals Inc is a United States-based biotechnology company. The company is focused on developing and commercializing DNA medicines to help treat and protect people from HPV-associated diseases, cancer and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.